Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Korde is Head of Breast Cancer Therapeutics, Cancer Therapy Evaluation Program, Division of Cancer Treatment & Diagnosis at the National Cancer Insitute (NCI). She received a Bachelor of Arts degree from the College of William and Mary in 1992, an MD from New York Medical College in 1998, and a master's degree in public health from the George Washington University in 2003. Dr. Korde completed her residency in Internal Medicine at Georgetown University Medical Center, and completed her Medical Oncology fellowship and a Cancer Prevention fellowship at the NCI, and then joined the Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, NCI as a staff clinician. Dr. Korde joined the Breast Medical Oncology faculty at Seattle Cancer Care Alliance in July 2009.
Dr. Korde has worked on a number of clinical and epidemiologic studies focusing on individuals at increased risk for cancer. Her research focuses on applying epidemiologic methods and genetic knowledge to better understand and treat breast cancer and manage therapy-related toxicities.